Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 39 of 529 for:    ALS (Amyotrophic Lateral Sclerosis)

Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03068754
Recruitment Status : Terminated (As recommended by the study's independent Data and Safety Monitoring Board (DSMB))
First Posted : March 3, 2017
Last Update Posted : October 18, 2019
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 27, 2019
Actual Study Completion Date : September 27, 2019